Jordan: When Data is Strong but Early Detection Still Lags

Jordan has long been recognised as one of the Middle East’s leading centres for medical expertise. Despite having fewer financial resources than many of its Gulf neighbours, the country has built a healthcare system that combines strong clinical capabilities with a well-established tradition of medical education and regional service delivery. Jordanian hospitals and medical professionals regularly attract patients from across the region, and the country has historically been at the forefront of advanced medical procedures, including organ transplantation and specialised cancer treatment.

With a population of roughly 11 million and a median age of just over 22 years, Jordan remains a relatively young society. Over recent decades, life expectancy has increased significantly, from around 53 years in 1960 to nearly 75 years today, reflecting substantial progress in public health and access to care. At the same time, economic constraints and demographic pressures continue to shape how healthcare services are delivered.

These dynamics are particularly visible in oncology. Cancer has become the second leading cause of death in Jordan, accounting for nearly one in five deaths nationwide. As life expectancy increases and risk factors evolve, the number of cancer cases continues to rise steadily, placing growing pressure on the healthcare system.

Like many countries in the region, Jordan is now confronting the challenge of expanding cancer prevention, early detection, and treatment capacity while managing limited resources.

Jordan’s cancer challenge today is not determined by a lack of knowledge or expertise.

It is defined by how effectively that knowledge is translated into early detection.

Understanding Jordan’s Cancer Burden

One of Jordan’s most important assets in cancer control is its ability to measure the disease with precision. The Jordan Cancer Registry, established in 1996 with compulsory reporting, has produced more than two decades of continuous national data, offering a detailed and reliable picture of cancer trends across the country.

In 2022 alone, more than 10,700 new cancer cases were recorded, including 8,754 among Jordanians and over 2,000 among non-Jordanians, meaning that nearly one in five cases occurs outside the citizen population.

The age-standardised incidence rate has reached approximately 157 cases per 100,000 people, with slightly higher rates among women than men. At the same time, cancer now accounts for roughly 16–20% of all deaths in the country, making it the second leading cause of mortality.

These figures reflect more than a growing burden. They reflect a system that is increasingly capable of understanding cancer in depth, its distribution, its evolution over time, and its impact on different population groups. Nearly 43% of cases are diagnosed in individuals aged 60 and above, while the average age at diagnosis is around the mid-fifties, placing a significant share of the burden on people in their most economically active years.

And yet, this strength in data has not fully translated into early detection.

Prevention and Early Detection: A Structural Gap

Despite having one of the region’s more established cancer surveillance systems, Jordan still lacks a comprehensive, nationwide screening framework across major cancer types. Breast cancer screening programmes are in place, but organised screening for other high-burden cancers, such as colorectal cancer, remains limited and is only now being developed at the national level.

This creates a subtle but important gap. The country can observe cancer trends with increasing clarity and accuracy, but is less able to systematically intercept the disease at earlier stages across the population.

Jordan’s national cancer control strategy recognises this imbalance explicitly. Expanding early detection, strengthening referral pathways, and improving screening coverage are central priorities for the coming years.

In other words, the challenge is no longer identifying the problem. It is acting early enough on what is already known.

Rising Demand and System Pressures

At the same time, demand for cancer services is rising rapidly. Demographic trends, including population growth and increasing life expectancy, now approaching 75 years, are contributing to a steady increase in cancer incidence. Some projections suggest that the number of new cases could rise by as much as 50% over the next decade, potentially exceeding 13,000 diagnoses annually.

This growing demand is placing pressure on a system that is already operating within financial and structural constraints. Cancer care alone costs more than 140 million Jordanian dinars each year, while health financing remains fragmented and unevenly distributed.

At the same time, preventive care remains relatively underdeveloped. Public spending continues to be heavily concentrated on hospital services, which account for more than three-quarters of public health expenditure, while primary care, where early detection should begin, plays a more limited role.

These structural dynamics reinforce a model of care that is still largely reactive.

Risk Factors and the Future Burden

The country’s risk factor profile further intensifies the challenge.

Jordan has one of the highest smoking rates in the region, with recent estimates suggesting that more than half of adult men use tobacco products. At the same time, obesity and physical inactivity are widespread, with over 40% of women and a quarter of men classified as obese, and more than three-quarters of adults not engaging in regular vigorous physical activity.

These patterns are already visible in the epidemiological data. Lung, colorectal, and breast cancers continue to rank among the most common diagnoses, and their incidence is expected to rise further in the absence of stronger preventive and early detection strategies.

A Regional Hub for Oncology Care

Despite these pressures, Jordan retains a strong clinical foundation. Institutions such as the King Hussein Cancer Center have built international reputations for high-quality oncology care, and the country continues to serve as a regional hub for specialised treatment.

However, as acknowledged in the national strategy, cancer care in Jordan has historically been more focused on treatment than on prevention or early diagnosis.

This imbalance is not uncommon, but in Jordan it is particularly visible: a system that performs well in treating cancer is still evolving in its ability to detect it early at scale.

Looking Ahead: From Data to Action

Jordan is now entering a new phase in its cancer control strategy. The National Cancer Control Strategy 2026–2030 sets out a more integrated approach, combining prevention, early detection, treatment, and data-driven policy into a single coordinated framework.

The country already possesses many of the necessary components: a functioning cancer registry, strong clinical institutions, and growing international collaboration.

The next step is alignment.

Aligning data with action.
Aligning diagnosis with timing.
Aligning medical capability with population-level engagement.

In Jordan, the challenge is no longer understanding cancer.

It is ensuring that the system responds early enough to what it already knows.

For country-specific insights, explore the full series:

Kuwait: Modern Healthcare and the Challenge of Early Cancer Detection

Iraq: Rebuilding Cancer Care in a Fragile Health System – Capacity, Access, and Continuity in Post-Conflict Oncology

Saudi Arabia: National Transformation Meets the Challenge of Early Cancer Detection

For a broader regional perspective, see: Early Cancer Detection in the Middle East: Why Technology Alone Is Not Enough